A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxis

被引:141
|
作者
Kainulainen, V
Sundvall, M
Määttä, JA
Santiestevan, E
Klagsbrun, M
Elenius, K
机构
[1] Univ Turku, Medicity Res Labs, FIN-20520 Turku, Finland
[2] Univ Turku, Dept Pediat, FIN-20520 Turku, Finland
[3] Univ Turku, Dept Med Biochem & Mol Biol, FIN-20520 Turku, Finland
[4] Childrens Hosp, Dept Surg, Boston, MA 02115 USA
[5] Childrens Hosp, Dept Pathol, Boston, MA 02115 USA
[6] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
D O I
10.1074/jbc.275.12.8641
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ErbB4 is a member of the epidermal growth factor receptor (ErbB) family that mediates cellular responses activated by neuregulins (NRG) and other epidermal growth factor-like growth factors. TWO naturally occurring ErbB4 isoforms, ErbB4 CYT-1 and ErbB4 CYT-2, have previously been identified. Unlike ErbB4 CYT-1, ErbB4 CYT-2 lacks a phosphoinositide 3-kinase (PIS-K)binding site and is incapable of activating PI3-K. We have now examined the consequences of the inability of this isoform to activate PI3-K on cell proliferation, survival, and chemotaxis in response to NRG-1 beta: (i) NRG-1 beta stimulated proliferation of cells expressing either ErbB4 CYT-1 or ErbB4 CYT-S, Consistent with the mitogenic responsiveness, analysis of downstream signaling showed that Shc and MAPK were phosphorylated after stimulating either isoform with NRG-1 beta. (ii) NRG-1 beta protected cells expressing ErbB4 CYT-1 but not cells expressing ErbB4 CYT-Q from starvation-induced apoptosis as measured by effects on cell number and 4',6-diamidino-2-phenylindole staining. Furthermore, in cells expressing ErbB4 CYT-2, Akt, a protein kinase that mediates cell survival, was not phosphorylated. (iii) NRG-1 beta stimulated chemotaxis and membrane ruffling in cells expressing ErbB4 CYT-1 but not in cells expressing ErbB4 CYT-8, In summary, ErbB4 CYT-8 can mediate proliferation but not chemotaxis or survival. These results suggest a novel mechanism by which cellular responses such as chemotaxis and survival may be regulated by the expression of alternative receptor-tyrosine kinase isoforms that differ in their coupling to PI3-K signaling.
引用
收藏
页码:8641 / 8649
页数:9
相关论文
共 43 条
  • [1] Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase
    Klaus Elenius
    Caroline J Choi
    Subroto Paul
    Eric Santiestevan
    Eiichiro Nishi
    Michael Klagsbrun
    Oncogene, 1999, 18 : 2607 - 2615
  • [2] Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase
    Elenius, K
    Choi, CJ
    Paul, S
    Santiestevan, E
    Nishi, E
    Klagsbrun, M
    ONCOGENE, 1999, 18 (16) : 2607 - 2615
  • [3] TNF-α and leptin activate the α-isoform of class II phosphoinositide 3-kinase
    Ktori, C
    Shepherd, PR
    O'Rourke, L
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 306 (01) : 139 - 143
  • [4] The p110α isoform of phosphoinositide 3-kinase is essential for cone photoreceptor survival
    Rajala, Raju V. S.
    Ranjo-Bishop, Michelle
    Wang, Yuhong
    Rajala, Ammaji
    Anderson, Robert E.
    BIOCHIMIE, 2015, 112 : 35 - 40
  • [5] Targeting the phosphoinositide 3-kinase isoform p110δ impairs growth and survival in neuroblastoma cells
    Boller, Danielle
    Schramm, Alexander
    Doepfner, Kathrin T.
    Shalaby, Tarek
    von Bueren, Andre O.
    Eggert, Angelika
    Grotzer, Michael A.
    Arcaro, Alexandre
    CLINICAL CANCER RESEARCH, 2008, 14 (04) : 1172 - 1181
  • [6] Effects of Novel Isoform-Selective Phosphoinositide 3-Kinase Inhibitors on Natural Killer Cell Function
    Yea, Sung Su
    So, Lomon
    Mallya, Sharmila
    Lee, Jongdae
    Rajasekaran, Kamalakannan
    Malarkannan, Subramaniam
    Fruman, David A.
    PLOS ONE, 2014, 9 (06):
  • [7] Targeting the Phosphoinositide 3-Kinase p110-α Isoform Impairs Cell Proliferation, Survival, and Tumor Growth in Small Cell Lung Cancer
    Wojtalla, Anna
    Fischer, Barbara
    Kotelevets, Nataliya
    Mauri, Francesco A.
    Sobek, Jens
    Rehrauer, Hubert
    Wotzkow, Carlos
    Tschan, Mario P.
    Seckl, Michael J.
    Zangemeister-Wittke, Uwe
    Arcaro, Alexandre
    CLINICAL CANCER RESEARCH, 2013, 19 (01) : 96 - 105
  • [8] Targeted inhibition of the phosphoinositide 3-kinase impairs cell proliferation, survival, and invasion in colon cancer
    Yang, Fei
    Gao, Jun-Yi
    Chen, Hua
    Du, Zhen-Hua
    Zhang, Xue-Qun
    Gao, Wei
    ONCOTARGETS AND THERAPY, 2017, 10 : 4413 - 4422
  • [9] Essential role for the p110δ isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia
    Sujobert, P
    Bardet, V
    Cornillet-Lefebvre, P
    Hayflick, JS
    Prie, N
    Verdier, F
    Vanhaesebroeck, B
    Muller, O
    Pesce, F
    Ifrah, N
    Hunault-Berger, M
    Berthou, C
    Villemagne, B
    Jourdan, E
    Audhuy, B
    Solary, E
    Witz, B
    Harousseau, JL
    Himberlin, C
    Lamy, T
    Lioure, B
    Cahn, JY
    Dreyfus, F
    Mayeux, P
    Lacombe, C
    Bouscary, D
    BLOOD, 2005, 106 (03) : 1063 - 1066
  • [10] Proliferation and survival of activated B cells requires sustained antigen receptor engagement and phosphoinositide 3-kinase activation
    Donahue, AC
    Fruman, DA
    JOURNAL OF IMMUNOLOGY, 2003, 170 (12): : 5851 - 5860